Isolation of a Second Recombinant Human Respiratory Syncytial Virus Monoclonal Antibody Fragment (Fab RSVF2-5) that Exhibits Therapeutic Efficacy In Vivo

Verfasser / Beitragende:
[James E. Crowe, Page S. Gilmour, Brian R. Murphy, Robert M. Chanock, Lingxun Duan, Roger J. Pomerantz, Glenn R. Pilkington]
Ort, Verlag, Jahr:
1998
Enthalten in:
Journal of Infectious Diseases, 177/4(1998-04), 1073-1076
Format:
Artikel (online)
ID: 39825124X